News

Thu 22 Aug 2024

DREAMS: when AI finds drugs for rare diseases

Discover on the DREAMS project website how Kantify contributes to the discovery of therapeutic targets and treatments for 5 rare neuromuscular disorders

Tue 30 Jul 2024

AI unveils secret targets of drugs, starting with Viagra

In a new White Paper, Kantify presents its AI powered Drug Atlas and unveils the predicted targets for Sildenafil (Viagra)

Wed 24 Jul 2024

A new name for the Kantify AI platform for drug discovery

Kantify shares the new name for its AI platform for small molecule and target discovery

Thu 11 Jul 2024

Kantify to speak at Science for Health

Join us at Science for Health, the flagship event Biology meets technology: AI, Data & Digitalization

Tue 30 Apr 2024

New poster on AI for drug discovery for muscular dystrophies

At Myology 2024, Emilie PELLIER & Quentin MIAGOUX from i-Stem presented our collaboration on AI powered target and drug discovery for LGMDR2

Tue 02 Apr 2024

Kantify reveals promising results in sarcoma at ESMO

Kantify Unveiled Promising Results in Liposarcoma Drug Discovery thanks to AI at ESMO Sarcoma and Rare Cancer Congress 2024

Tue 19 Mar 2024

Nicolas Maignan appointed Chief Operating Officer of Kantify

Announcement: Nicolas Maignan is officially appointed COO of Kantify

Thu 14 Mar 2024

AI for Healthcare panel at the Pharma.be General Assembly

Kantify was invited at the pharma.be special panel on AI for Healthcare

Mon 11 Mar 2024

Poster at ESMO : AI for target and drug discovery in sarcoma

Kantify will share its latest results on rapid identification of novel targets and polypharmacological compounds for liposarcoma treatment, thanks to AI

Mon 11 Dec 2023

Kantify at Belgium's Biopharmaceutical Excellence Conference

Kantify shared some of its groundbreaking work at the Conference on the Belgian biopharmaceutical sector organized by the Federal Ministry of Foreign Affairs

Thu 07 Dec 2023

Appointment of Dr Eckhard von Keutz as Scientific Advisor

Kantify appoints Dr von Keutz, former Vice-President at Bayer Pharmaceuticals, as Scientific Advisor

Wed 29 Nov 2023

Kantify will use its AI platform to tackle 5 rare diseases

Kantify is selected by the European Commission to perform an unprecedented research project on rare diseases and AI